Blue Economy vision and ecological responsibility
India’s ambitious Blue Economy vision is reshaping the way the country engages with its vast marine resources.
India’s ambitious Blue Economy vision is reshaping the way the country engages with its vast marine resources.
The recently concluded Maha Kumbh has not only reinforced Uttar Pradesh Chief Minister Yogi Adityanath’s political dominance in the state but has also positioned him as a key contender in any post-Narendra Modi succession debate.
UK Prime Minister Keir Starmer’s visit to Washington was important for transatlantic diplomacy. It was his first official engagement with President Donald Trump, a leader known for his forceful style and unpredictable rhetoric.
The statement “Europe is dying, long live Europe” is neither a casual truism nor a dramatic drumbeat, but suggests a profound transformation of the continent, particularly after a devastating three-year period of the Russia Ukraine conflict.
Homestay in the Himalayas is a rapidly emerging concept that goes beyond sightseeing. It focuses on making real connections with people, culture, and nature as part of the travel experience.
The explosive confrontation between President Donald Trump and President Volodymyr Zelenskky has exposed a widening gulf in the US-Ukraine relationship, leaving Kyiv more vulnerable at a critical moment in its war against Russia.
The release of Israel’s official military report on the failures of 7 October 2023 marks a critical moment in the country’s reckoning with one of its darkest days.
On the afternoon of 5 February 2025, a US military aircraft landed at Amritsar’s Shri Guru Ramdas Ji International Airport, carrying 104 Indian immigrants who had entered the United States illegally.
India’s clean energy ambitions are bold and necessary, but the country faces an uphill battle in turning them into reality.
India stands at a crossroads in the global clinical trials market. Despite its vast and diverse patient pool, cost-effective medical ecosystem, and expanding hospital network, the country holds a mere 8 per cent share in global trials, significantly lagging behind China’s 29 per cent and America's 25 per cent.
